ARTICLE | Company News
EpiCept, Immune Pharmaceuticals deal
September 2, 2013 7:00 AM UTC
The companies completed their merger into combined company Immune Pharmaceuticals Inc. Immune Pharmaceuticals Inc. said that EpiCept shareholders hold about 19% of the newco's stock and Immune Pharma...